Palvella Therapeutics (PVLA) Tax Provisions (2014 - 2018)
Palvella Therapeutics (PVLA) reported Tax Provisions of -$164000.0 for Q4 2018, down 213.89% year-over-year from $144000.0 in Q4 2017, and down 10.81% on a QoQ basis from -$148000.0 in Q2 2018.
Palvella Therapeutics (PVLA) has 4 years of Tax Provisions data on file, last reported at -$164000.0 in Q4 2018.
- Quarterly Tax Provisions fell 213.89% year-over-year to -$164000.0 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was -$164000.0 (down 4000.0% YoY) and the FY2020 annual result came in at $164000.0, changed N/A from the prior year.
- Tax Provisions declined to -$164000.0 in Q4 2018 per PVLA's latest filing, from -$148000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $814000.0 in Q2 2017 and bottomed at -$164000.0 in Q4 2018.
- The 4-year median for Tax Provisions is $40441.0 (2015), against an average of $110647.8.
- Peak annual rise in Tax Provisions reached 118.18% in 2018, while the deepest fall reached 213.89% in 2018.
- Tracing PVLA's Tax Provisions over 4 years: stood at -$18.0 in 2014, then jumped by 908016.67% to $163425.0 in 2015, then decreased by 11.89% to $144000.0 in 2017, then tumbled by 213.89% to -$164000.0 in 2018.
- Per Business Quant, the three latest PVLA Tax Provisions figures stand at -$164000.0 (Q4 2018), -$148000.0 (Q2 2018), and $144000.0 (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -164,000.00 |
| Jun 30, 2018 | -148,000.00 |
| Dec 31, 2017 | 144,000.00 |
| Sep 30, 2017 | 146,000.00 |
| Jun 30, 2017 | 814,000.00 |
| Dec 31, 2015 | 163,425.00 |
| Sep 30, 2015 | 40,441.00 |
| Jun 30, 2014 | -18.00 |
| Mar 31, 2014 | -18.00 |